Trial update
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis: registry status update
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
Loading research and source information…
Source-dated updates from the selected studies. A recent check does not mean the registry record itself changed recently.
208 developments · Showing 193–196
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports completed. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.